tafolecimab
innovent biologics
['ibi306', 'tafolecimab', 'innovent', 'imab ', '$ivbiy']
innovent releases results of a phase 3 clinical study of tafolecimab ibi306 in chinese patients with non- familial hypercholesterolemia at the american heart.. $ivbiy 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice